Barrett FS

Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Barrett FS

An Open-Label Multidose Psilocybin Intervention for Obsessive-Compulsive Disorder

Moving beyond 5-HT&lt;sub&gt;2A&lt;/sub&gt;: language models map neurotransmitter receptors to experiential semantics.

Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session.

Psychedelics align brain activity with context.

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings.

Psilocybin-induced neurocardiogenic syncope: a case report.

Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations

An international mega-analysis of psychedelic drug effects on brain circuit function.

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.

Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds.

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics.

Cognitive control as a transdiagnostic mechanism of action in psychedelic effects.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.

Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Teaching a new dog old tricks: bringing rigor, grounding, and specificity to psychedelic neuropsychopharmacology.

Development of the Japanese version of the Challenging Experience Questionnaire.

Impact of Psilocybin on Peripheral Cytokine Production.

The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.

Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.

The psychedelic effects of cannabis: A review of the literature.

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.

Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies.

Learned Helplessness As a Potential Transdiagnostic Therapeutic Mechanism of Classic Psychedelics.

Corrigendum to 'Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity': Neuroimage 2022 Oct 15;260:119434.

Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.

Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.

Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.

Unique Effects of Sedatives, Dissociatives, Psychedelics, Stimulants, and Cannabinoids on Episodic Memory: A Review and Reanalysis of Acute Drug Effects on Recollection, Familiarity, and Metamemory

Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.

Models of psychedelic drug action: modulation of cortical-subcortical circuits.

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [<sup>11</sup>C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.

Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.

Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities.

Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.

Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports

Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches.

Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.

The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain.

Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention.

Emotions and brain function are altered up to one month after a single high dose of psilocybin.

Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music.

Psychedelics and music: neuroscience and therapeutic implications.

Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.

"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.

Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

Moving beyond 5-HT<sub>2A</sub>: language models map neurotransmitter receptors to experiential semantics.